| Primary |
| Cardiac Failure |
21.4% |
| Fluid Retention |
14.3% |
| Hypothyroidism |
14.3% |
| Migraine |
14.3% |
| Hypertension |
7.1% |
| Ill-defined Disorder |
7.1% |
| Ischaemic Cardiomyopathy |
7.1% |
| Oedema |
7.1% |
| Pain |
7.1% |
|
| Death |
14.3% |
| Cardiac Disorder |
10.7% |
| Drug Hypersensitivity |
7.1% |
| Lip Swelling |
7.1% |
| Neoplasm Skin |
7.1% |
| Bradycardia |
3.6% |
| Bronchitis |
3.6% |
| Cerebrovascular Accident |
3.6% |
| Drug Dispensing Error |
3.6% |
| Headache |
3.6% |
| Hypersensitivity |
3.6% |
| Hypothyroidism |
3.6% |
| Impaired Work Ability |
3.6% |
| Influenza |
3.6% |
| Porphyria |
3.6% |
| Refusal Of Treatment By Patient |
3.6% |
| Renal Failure |
3.6% |
| Renal Failure Acute |
3.6% |
| Swelling Face |
3.6% |
| Tachycardia |
3.6% |
|
| Secondary |
| Drug Use For Unknown Indication |
25.2% |
| Hypertension |
20.4% |
| Product Used For Unknown Indication |
16.3% |
| Type 2 Diabetes Mellitus |
5.4% |
| Depression |
4.1% |
| Multiple Myeloma |
4.1% |
| Back Pain |
3.4% |
| Essential Hypertension |
2.7% |
| Ill-defined Disorder |
2.0% |
| Pain |
2.0% |
| Spinal Fracture |
2.0% |
| Atrial Fibrillation |
1.4% |
| Blood Pressure Abnormal |
1.4% |
| Cardiac Failure |
1.4% |
| Diuretic Therapy |
1.4% |
| Gastritis |
1.4% |
| General Physical Health Deterioration |
1.4% |
| Gout |
1.4% |
| Hiatus Hernia |
1.4% |
| Hypercholesterolaemia |
1.4% |
|
| Renal Failure Acute |
15.9% |
| Hyponatraemia |
11.4% |
| Tremor |
9.1% |
| Vomiting |
9.1% |
| Lactic Acidosis |
6.8% |
| Weight Decreased |
6.8% |
| Cardiac Disorder |
4.5% |
| Death |
4.5% |
| Orthostatic Hypotension |
4.5% |
| Ventricular Tachycardia |
4.5% |
| Agranulocytosis |
2.3% |
| Aspartate Aminotransferase Increased |
2.3% |
| Atrial Fibrillation |
2.3% |
| Cardiac Failure |
2.3% |
| Confusional State |
2.3% |
| Dehydration |
2.3% |
| Fall |
2.3% |
| General Physical Health Deterioration |
2.3% |
| Hearing Impaired |
2.3% |
| Hyperkalaemia |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
19.9% |
| Hypertension |
18.6% |
| Drug Use For Unknown Indication |
16.3% |
| Depression |
4.7% |
| Rheumatoid Arthritis |
4.3% |
| Diabetes Mellitus |
3.6% |
| Hypothyroidism |
3.2% |
| Multiple Myeloma |
3.1% |
| Blood Cholesterol Increased |
2.6% |
| Cardiac Disorder |
2.6% |
| Chronic Obstructive Pulmonary Disease |
2.6% |
| Atrial Fibrillation |
2.4% |
| Device Related Infection |
2.4% |
| Pulmonary Arterial Hypertension |
2.3% |
| Hormone Replacement Therapy |
2.2% |
| Osteopenia |
2.2% |
| Pain |
2.0% |
| Breast Cancer |
1.7% |
| Gastrooesophageal Reflux Disease |
1.7% |
| General Anaesthesia |
1.6% |
|
| Weight Increased |
9.5% |
| Vomiting |
8.6% |
| Urinary Tract Infection |
7.6% |
| Vitreous Haemorrhage |
7.6% |
| White Blood Cell Count Increased |
7.6% |
| Myocardial Infarction |
5.7% |
| Tuberculosis |
5.7% |
| Rash |
4.8% |
| Renal Failure Acute |
4.8% |
| Wheezing |
4.8% |
| Eosinophilia |
3.8% |
| Pneumonia |
3.8% |
| Speech Disorder |
3.8% |
| Trismus |
3.8% |
| Wound |
3.8% |
| Arrhythmia |
2.9% |
| Electrocardiogram Qt Prolonged |
2.9% |
| Oedema Peripheral |
2.9% |
| Pulmonary Arterial Hypertension |
2.9% |
| Pulmonary Embolism |
2.9% |
|
| Interacting |
| Ill-defined Disorder |
30.8% |
| Spinal Compression Fracture |
23.1% |
| Hypertension |
15.4% |
| Depression |
7.7% |
| Essential Hypertension |
7.7% |
| Optic Neuritis |
7.7% |
| Prophylaxis |
7.7% |
|
| Renal Failure Acute |
50.0% |
| Drug Interaction |
25.0% |
| Hyponatraemia |
25.0% |
|
